The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FusionVAC22_01: A phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion.
 
Jonas S. Heitmann
Employment - BiconY Therapeutics
Travel, Accommodations, Expenses - Synimmune
 
Michael Bitzer
Consulting or Advisory Role - Bayer/Vital; Bristol-Myers Squibb; Eisai Germany; Incyte; MSD Sharp & Dome GmbH; Roche Pharma AG; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Merck
 
Christopher Hackenbruch
No Relationships to Disclose
 
Jens Bauer
Patents, Royalties, Other Intellectual Property - EP21214728.4
 
Yacine Maringer
Patents, Royalties, Other Intellectual Property - EP21214728.4
 
Annika Nelde
Patents, Royalties, Other Intellectual Property - EP21214728.4
 
Helmut R. Salih
Stock and Other Ownership Interests - Immatics
Consulting or Advisory Role - Novartis; Pfizer; Philogen; Synimmune
Research Funding - ABL Bio
Patents, Royalties, Other Intellectual Property - Inventor on several patents in the field of caner immunotherapy
(OPTIONAL) Uncompensated Relationships - TWYCE GmbH
 
Juliane S. Walz
Stock and Other Ownership Interests - ViferaXS
Consulting or Advisory Role - OrganoidScience; SwarmOncology
Research Funding - Roche
Patents, Royalties, Other Intellectual Property - Inventor on a patent on the peptides mentioned in the abstract